Relationship between the Prenatal Diagnosis of Placenta Acreta Spectrum and Lower Use of Blood Components.
Relação entre o diagnóstico prenatal de espectro da placenta acreta e menor uso de hemoderivados.
Journal
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
ISSN: 1806-9339
Titre abrégé: Rev Bras Ginecol Obstet
Pays: Brazil
ID NLM: 9214757
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
entrez:
29
12
2022
pubmed:
30
12
2022
medline:
3
1
2023
Statut:
ppublish
Résumé
To describe the clinical results of patients admitted and managed as cases of placenta accreta spectrum (PAS) at a Central American public hospital and the influence of the prenatal diagnosis on the condition. A retrospective analysis of PAS patients treated at Hospital Bertha Calderón Roque, in Managua, Nicaragua, between June 2017 and September 2021. The diagnostic criteria used were those of the International Federation of Gynecology and Obstetrics (Fédération Internationale de Gynécologie et d'Obstétrique, FIGO, in French). The population was divided into patients with a prenatal ultrasonographic diagnosis of PAS (group 1) and those whose the diagnosis of PAS was established at the time of the caesarean section (group 2). During the search, we found 103 cases with a histological and/or clinical diagnosis of PAS; groups 1 and 2 were composed of 51 and 52 patients respectively. Regarding the clinical results of both groups, the patients in group 1 presented a lower frequency of transfusions (56.9% versus 96.1% in group 2), use of a lower number of red blood cell units (RBCUs) among those undergoing transfusions (median: 1; interquartile range: [IQR]: 0-4 versus median: 3; [IQR]: 2-4] in group 2), and lower frequency of 4 or more RBCU transfusions (29.4% versus 46.1% in group 2). Group 1 also exhibited a non-significant trend toward a lower volume of blood loss (1,000 mL [IQR]: 750-2,000 mL versus 1,500 mL [IQR]: 1,200-1,800 mL in group 2), and lower requirement of pelvic packing (1.9% versus 7.7% in group 2). Establishing a prenatal diagnosis of PAS is related to a lower frequency of transfusions. We observed a high frequency of prenatal diagnostic failures of PAS. It is a priority to improve prenatal detection of this disease.
Identifiants
pubmed: 36580936
doi: 10.1055/s-0042-1758712
pmc: PMC9800148
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1090-1093Informations de copyright
Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Déclaration de conflit d'intérêts
The authors have no conflict of interests to declare.
Références
Transfus Med Rev. 2018 Oct;32(4):244-248
pubmed: 30025661
Am J Obstet Gynecol. 2017 Jul;217(1):27-36
pubmed: 28268196
Int J Gynaecol Obstet. 2018 Mar;140(3):281-290
pubmed: 29405317
Int J Gynaecol Obstet. 2019 Jul;146(1):20-24
pubmed: 31173360
Acta Obstet Gynecol Scand. 2018 Oct;97(10):1219-1227
pubmed: 29797715
Int J Obstet Anesth. 2013 Nov;22(4):273-9
pubmed: 23932233
J Clin Ultrasound. 2014 Oct;42(8):449-55
pubmed: 24975386
Am J Obstet Gynecol. 2015 May;212(5):561-8
pubmed: 25460838
J Matern Fetal Neonatal Med. 2022 Dec;35(25):6104-6111
pubmed: 33843408
Am J Obstet Gynecol. 2019 Jun;220(6):511-526
pubmed: 30849356
Acta Obstet Gynecol Scand. 2013 Apr;92(4):439-44
pubmed: 23331024
Aust N Z J Obstet Gynaecol. 2022 Jun;62(3):376-382
pubmed: 34984671
BJOG. 2014 Jan;121(1):62-70; discussion 70-1
pubmed: 23924326